Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data

Epstein, S., Xia, Z., Lee, A. J., Dahl, M., Edwards, K., Levit, E., Longbrake, E. E., Perrone, C., Kavak, K., Weinstock-Guttman, B., Diallo, F., Ricci, A., Riley, C. S., De Jager, P. L., Farber, R., & Wesley, S. F. (2022). Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data. Multiple Sclerosis and Related Disorders, 57, 103433. https://doi.org/10.1016/j.msard.2021.103433
Authors:
Samantha Epstein
Zongqi Xia
Annie J. Lee
Megan Dahl
Keith Edwards
Elle Levit
Erin E. Longbrake
Christopher Perrone
Katelyn Kavak
Bianca Weinstock-Guttman
Fatoumata Diallo
Adelle Ricci
Claire S. Riley
Philip L. De Jager
Rebecca Farber
Sarah F. Wesley
Affiliated Authors:
Samantha Epstein
Annie J. Lee
Fatoumata Diallo
Adelle Ricci
Claire S. Riley
Philip L. De Jager
Rebecca Farber
Sarah F. Wesley
Columbia Affiliation:
Subjects:
COVID-19 (MeSH)
SARS-CoV-2 (MeSH)
elink
Publication Type:
Article
Unique ID:
10.1016/j.msard.2021.103433
PMID:
34923427
DOI:
10.1016/j.msard.2021.103433
Journal:
Multiple Sclerosis and Related Disorders
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View Web of Science Record
View PubMed Record

Record Created: